gastroenterology
Medicines

Infliximab access needed to treat immunotherapy-induced colitis

The increasing use of immunotherapies in cancer will lead to more cases of steroid-refractory colitis that can only be treated with infliximab, gastroenterologists predict. But the anti-TNF drug is not available on the PBS or hospital formularies for the treatment immunotherapy-related colitis, and so patients may be denied access to effective treatment for the serious, ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic